: Codexis stock drops as forecast comes in below Street estimate


Codexis Inc. CDXS shares fell in the extended session Thursday after the biotech company lowered its revenue forecast for the year and said that sales from Pfizer Inc. PFE would come in at the low end of an expected range. Codexis shares dropped more than 20% after hours, following a 4.7% decline in the regular session to close at $12.07. The company said it now expects full-year revenue of $135 million to $141 million, compared with a previous forecast of $152 million to $158 million, with second-quarter revenue around $38 million, as R&D partnerships are expected to bring in less money than initially thought. Analysts…

This article was originally published by Marketwatch.com. Read the original article here.

Previous articleKey Words: Trump lost, and the 2020 election wasn’t stolen, group of prominent conservatives concludes after exhaustive study
Next articleIvana Trump, ex-wife of former President Trump, dies at 73


Please enter your comment!
Please enter your name here